Home › Funds › Royce & Associates › INSM
Royce & Associates position in INSM
INSMED INC · Health Care
Latest position (Q4 2025)59.70K sh
Reported value held$10.39M
Portfolio Weight0.11%
First reportedQ2 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 95.03K | $6.37M | New |
| Q3 2024 | 95.03K | $6.94M | Hold |
| Q4 2024 | 90.03K | $6.22M | Reduce |
| Q1 2025 | 90.03K | $6.87M | Hold |
| Q2 2025 | 90.03K | $9.06M | Hold |
| Q3 2025 | 92.38K | $13.30M | Add |
| Q4 2025 | 59.70K | $10.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding INSM
- Vanguard Group 21.08M sh · $3.67B · Q4 2025
- Fidelity Management & Research (FMR) 16.14M sh · $1.72B · Q2 2026
- BlackRock Inc 15.81M sh · $1.69B · Q2 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- Geode Capital Management 4.22M sh · $448.76M · Q2 2026
- Norges Bank Investment Management 3.38M sh · $360.12M · Q2 2026
- Millennium Management 2.93M sh · $312.21M · Q2 2026
- Franklin Resources 2.27M sh · $242.37M · Q2 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- Balyasny Asset Management 1.34M sh · $143.20M · Q2 2026
- Northern Trust Corp 1.32M sh · $140.24M · Q2 2026
- BNY Mellon 1.31M sh · $139.97M · Q2 2026